Cargando…
The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune condition that can potentially affect every single organ during the course of the disease, leading to increased morbidity and mortality, and reduced health-related quality of life. While curative treatment is currently non-exist...
Autores principales: | Tan, Marcus Kai Xuan, Heng, Thurston Yan Jia, Mak, Anselm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523351/ https://www.ncbi.nlm.nih.gov/pubmed/30959892 http://dx.doi.org/10.3390/cells8040323 |
Ejemplares similares
-
The Pathology of T Cells in Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014) -
N-acetylcysteine as an adjunct treatment of schizophrenia
por: Freitas, R. Mota, et al.
Publicado: (2021) -
Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin
por: Kudaravalli, Jyothsna
Publicado: (2011) -
Environmental Factors, Toxicants and Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014) -
T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
por: Mak, Anselm
Publicado: (2022)